|
26
|
115
|
7ozuB |
Sars-cov-2 rdrp with molnupiravir/ nhc in the template strand base-paired with a |
|
232
|
899
|
7ozuA |
Sars-cov-2 rdrp with molnupiravir/ nhc in the template strand base-paired with a |
|
12
|
81
|
7oygB |
Dimeric form of sars-cov-2 rna-dependent rna polymerase |
|
74
|
306
|
7r7hA |
Peptidomimetic nitrile warheads as sars-cov-2 3cl protease inhibitors |
|
72
|
347
|
7rb2A |
Cryo-em structure of sars-cov-2 nsp15 nendou in bis-tris ph 6.0 |
|
71
|
347
|
7rb0A |
Cryo-em structure of sars-cov-2 nsp15 nendou at ph 7.5 |
|
88
|
304
|
7p35AAA |
Structure of the sars-cov-2 3cl protease in complex with rupintrivir |
|
94
|
523
|
7n0cB |
Cryo-em structure of the monomeric form of sars-cov-2 nsp10-nsp14 (e191a)-rna complex |
|
42
|
146
|
7miaA |
Maize rayado fino virus protease |
|
114
|
522
|
7n0dB |
Cryo-em structure of the tetrameric form of sars-cov-2 nsp10-nsp14 (e191a)-rna complex |
|
86
|
522
|
7n0bB |
Cryo-em structure of sars-cov-2 nsp10-nsp14 (wt)-rna complex |
|
30
|
131
|
7n0dA |
Cryo-em structure of the tetrameric form of sars-cov-2 nsp10-nsp14 (e191a)-rna complex |
|
82
|
301
|
7n44A |
Crystal structure of the sars-cov-2 (2019-ncov) main protease in complex with 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2h-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1h,3h)-dione (compound 13) |
|
77
|
303
|
7mbiA |
Structure of sars-cov2 3cl protease covalently bound to peptidomimetic inhibitor |
|
43
|
146
|
7micA |
Maize rayado fino virus protease in complex with ubiquitin |
|
30
|
127
|
7kriA |
Fr6-bound sars-cov-2 nsp9 rna-replicase |
|
24
|
72
|
7egqC |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
227
|
926
|
7egqA |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
57
|
187
|
7egqB |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
29
|
139
|
7araA |
Rhinovirus a2 2a protease in complex with zvam.fmk |
|
8
|
28
|
7ck5A |
Solution structure of 28 amino acid polypeptide (354-381) in plantago asiatica mosaic virus replicase bound to sds micelle |
|
20
|
131
|
7egqH |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
92
|
523
|
7egqK |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
345
|
1817
|
7ejuA |
Junin virus(junv) rna polymerase l complexed with z protein |
|
81
|
306
|
7lcoA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
83
|
306
|
7lctA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
83
|
306
|
7ldlA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
80
|
306
|
7lcsA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
86
|
299
|
7k0eA |
1.90 a resolution structure of sars-cov-2 3cl protease in complex with deuterated gc376 |
|
89
|
305
|
7aegA |
Sars-cov-2 main protease in a covalent complex with sdz 224015 derivative, compound 5 |
|
89
|
305
|
7aehA |
Sars-cov-2 main protease in a covalent complex with a pyridine derivative of abt-957, compound 1 |
|
82
|
301
|
7m8zA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 29 |
|
85
|
302
|
7m8xA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 6 |
|
77
|
305
|
7m90A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 50 |
|
85
|
305
|
7m91A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 25 |
|
86
|
301
|
7m8mA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 11 |
|
84
|
306
|
7n8cA |
Joint x-ray/neutron structure of sars-cov-2 main protease (mpro) in complex with mcule5948770040 |
|
82
|
301
|
7mgrA |
Sars-cov-2 main protease in complex with nsp8/9 substrate peptide |
|
88
|
306
|
7m8yA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 15 |
|
85
|
301
|
7m8oA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 19 |
|
82
|
306
|
7n89A |
Room-temperature x-ray structure of sars-cov-2 main protease c145a mutant in complex with substrate ac-savlqsgf-conh2 |
|
85
|
301
|
7m8nA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 16 |
|
89
|
295
|
7nh7A |
Oc43 coronavirus methyltransferase |
|
84
|
301
|
7m8pA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 23 |
|
87
|
305
|
7mgsA |
Sars-cov-2 main protease in complex with n-terminal autoprocessing substrate |
|
92
|
306
|
7cuuA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with mg132 |
|
85
|
305
|
7e19A |
Crystal structure of sar-cov-2 3cl protease complex with inhibitor sh-5 |
|
84
|
303
|
7e18A |
Crystal structure of sar-cov-2 3cl protease complex with inhibitor yh-53 |
|
80
|
301
|
7cutA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with z-vad-fmk |
|
91
|
306
|
7n5zA |
Sars-cov-2 main protease c145s mutant |
